Yong Eun Park1, Jae Hee Cheon2,3, Jihye Park1, Ji Hoon Lee1, Hyun Jung Lee1,4, Soo Jung Park1,4, Tae Il Kim1,4, Won Ho Kim1,4. 1. Department of Internal Medicine, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 03722, South Korea. 2. Department of Internal Medicine, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 03722, South Korea. geniushee@yuhs.ac. 3. Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, South Korea. geniushee@yuhs.ac. 4. Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, South Korea.
Abstract
PURPOSE: Patients with intestinal Behçet's disease who underwent intestinal resective surgery often require reoperation. However, there have been no studies on the risk factors and outcomes of early reoperation in these patients. METHODS: We retrospectively evaluated 41 patients with intestinal Behçet's disease who received repeated intestinal resective surgeries between 2006 and 2016. We analyzed two different patient groups-those who required early reoperation within 6 months and those who underwent reoperation >6 months after the initial surgery-and determined the risk factors for early reoperation. RESULTS: Eleven patients (26.8%) underwent reoperation within 6 months and 30 patients (73.2%) after 6 months. Emergency surgery at the initial operation and higher initial perioperative erythrocyte sedimentation rate and C-reactive protein levels were significantly associated with early reoperation in the univariate analysis. After the multivariate analysis, initial emergency operation (P = 0.020; hazard ratio [HR], 42.625; 95% confidence interval [CI], 1.817-1000.088) and high erythrocyte sedimentation rate (P = 0.039; HR, 1.049; 95% CI, 1.002-1.097) were determined to be the independent factors for early reoperation. CONCLUSIONS: Emergency surgery and high perioperative erythrocyte sedimentation rate levels were the prognostic factors for early reoperation (within 6 months) in patients with intestinal Behçet's disease after initial bowel resective surgery.
PURPOSE:Patients with intestinal Behçet's disease who underwent intestinal resective surgery often require reoperation. However, there have been no studies on the risk factors and outcomes of early reoperation in these patients. METHODS: We retrospectively evaluated 41 patients with intestinal Behçet's disease who received repeated intestinal resective surgeries between 2006 and 2016. We analyzed two different patient groups-those who required early reoperation within 6 months and those who underwent reoperation >6 months after the initial surgery-and determined the risk factors for early reoperation. RESULTS: Eleven patients (26.8%) underwent reoperation within 6 months and 30 patients (73.2%) after 6 months. Emergency surgery at the initial operation and higher initial perioperative erythrocyte sedimentation rate and C-reactive protein levels were significantly associated with early reoperation in the univariate analysis. After the multivariate analysis, initial emergency operation (P = 0.020; hazard ratio [HR], 42.625; 95% confidence interval [CI], 1.817-1000.088) and high erythrocyte sedimentation rate (P = 0.039; HR, 1.049; 95% CI, 1.002-1.097) were determined to be the independent factors for early reoperation. CONCLUSIONS: Emergency surgery and high perioperative erythrocyte sedimentation rate levels were the prognostic factors for early reoperation (within 6 months) in patients with intestinal Behçet's disease after initial bowel resective surgery.
Authors: Yoon Suk Jung; Jin Young Yoon; Jin Ha Lee; Soung Min Jeon; Sung Pil Hong; Tae Il Kim; Won Ho Kim; Jae Hee Cheon Journal: Inflamm Bowel Dis Date: 2010-11-08 Impact factor: 5.325
Authors: Jae Hee Cheon; Eun Soo Kim; Sung Jae Shin; Tae Il Kim; Kang Moon Lee; Sang Woo Kim; Joo Sung Kim; You Sun Kim; Chang Hwan Choi; Byong Duk Ye; Suk-Kyun Yang; Eun Hee Choi; Won Ho Kim Journal: Am J Gastroenterol Date: 2009-06-16 Impact factor: 10.864
Authors: Eun Ae Kang; Jung Won Park; Min Soo Cho; Jae Hee Cheon; Yehyun Park; Soo Jung Park; Tae Il Kim; Won Ho Kim Journal: BMC Gastroenterol Date: 2021-10-07 Impact factor: 3.067